Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
ESHG 2025 - Corporate Satellite
Real-world innovation in multi-omics with MGI and global experts
Explore how MGI’s DNBSEQ™ and STEREO-seq technologies are driving innovation across multi-omics; combining high-throughput DNA sequencing, single-cell analysis, and spatial transcriptomics. Deep dive into real-world innovation in population genomics, and clinical research.

This session will highlight real-world case studies in oncology, and national genomics initiatives, showcasing how integrated approaches are advancing clinical genomics and personalized healthcare.

Join us at Booth #310 and don’t miss this opportunity to connect with the people and platforms shaping the future of genomics.

📍Location: Amber 7 + 8, ESHG 2025

🗓 Date: Saturday, 24 May 2025

🕛 Time: 12:15 – 13:30

🍴 Complimentary lunch bags provided

💡 Where science meets impact. Where population health meets precision medicine. Join us at booth #310 for a glimpse into the future of multi-omics.
Meet our corporate satellite speakers who are at the forefront of genomics innovation
  • Prof. Janis Klovins

    Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia

    Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications

  • Dr. Eirini Papadopoulou
    International Laboratory Director, Genekor Medical S.A, Greece
    The Clinical Utility of Multigene Panel Analysis in Precision Oncology
  • Dr. Xin Jin
    Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
    Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB)
Featured Talks and Posters at ESHG 2025
Join our researchers in the official ESHG scientific program and discover the latest innovations in genomics, multi-omics, and clinical diagnostics.
  • Dr. Li Jiankang
    Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization
    Sunday, May 25
    Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights
  • Dr. Ya Gao
    Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus
    Sunday, May 25
    C21 - Prenatal and reproductive medicine
  • Dr. Wen-Jing Wang
    Early prediction of preterm birth with cell-free RNA
    Sunday, May 25
    C21 - Prenatal and reproductive medicine
  • Dr. Ji Yi
    Analysis of Macrophage Spatial Distribution and Tumor Microenvironment in Esophageal Squamous Cell Carcinoma Using Stereo-ClTE-seq
    E-poster
  • Dr. Heng Yi
    Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency
    E-poster
Introducing Our Next Innovations – Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.

Join us as we unveil the future of single-cell library prep
24 May | 16:10 | Booth #310
From Prep to Precision: Unlocking Efficiency in Single-Cell Research